86.90.E - Healthcare
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
58.11.Z - Publishing of books
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 53,3 | 10,8 | -7 | -164,8 |
EBITDA | 60,8 | 22,8 | 7,9 | -65,2 |
Short time liabilities | 35,1 | 16,8 | 21,1 | 25,7 |
Equity capital | 47,4 | 44,6 | 30,5 | -31,5 |
Operating profit (EBIT) | 55,2 | 16,1 | 1 | -94 |
Assets | 150,6 | 112,4 | 101,5 | -9,7 |
Net profit (loss) | 42,5 | 7,2 | -6,8 | -194,9 |
Cash | 0,5 | 0,5 | 0,7 | 36,3 |
Liabilities and provisions for liabilities | 103,2 | 67,8 | 70,9 | 4,6 |
Net income from sale | 344,4 | 294,5 | 318,7 | 8,2 |
Working assets | 120,8 | 83,1 | 74,9 | -9,8 |
Depreciation | 5,6 | 6,7 | 7 | 3,5 |
% | % | % | p.p. | |
Profitability of capital | 89,7 | 16,2 | -22,4 | -38,6 |
Equity capital to total assets | 31,5 | 39,7 | 30,1 | -9,6 |
Gross profit margin | 15,5 | 3,7 | -2,2 | -5,9 |
EBITDA Margin | 17,7 | 7,7 | 2,5 | -5,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 21 | 24 | 3 |
Current financial liquidity indicator | 1.7602934837341309 | 2.5178816318511963 | 1.9986333847045898 | -0,5 |
Net dept to EBITDA | 0.6233185529708862 | 1.6088672876358032 | 4.647032737731934 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane